Barinthus Biotherapeutics BRNS Growth Metrics (2020-2026)

NASDAQ BRNS
$0.61 +0.01 (+1.67%)
At close: Aug 20, 2026 · 4:00 PM EDT
Growth Metrics Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)
-2.91M166.95M0.29M4.82M2.93M-166.72M-0.46M-0.80M
EBITDA Margin Growth (3y) (Quarter)
-0.39M-0.70M2.91M
EBITDA Margin (QoQ) (Quarter)
1.90M169.59M-166.68M0.01M0.00M-0.05M-0.42M-0.33M
EBIT Margin Growth (1y) (Quarter)
-2.91M166.95M0.29M4.82M2.93M-166.72M-0.46M-0.80M
EBIT Margin Growth (3y) (Quarter)
-0.39M-0.70M2.91M
EBIT Margin (QoQ) (Quarter)
1.90M169.59M-166.68M0.01M0.00M-0.05M-0.42M-0.33M
EBT Margin Growth (1y) (Quarter)
-3.70M167.04M0.41M4.82M3.72M-166.72M-0.40M-0.76M
EBT Margin Growth (3y) (Quarter)
-0.33M-0.66M3.71M
EBT Margin (QoQ) (Quarter)
1.10M170.39M-166.68M0.01M0.00M-0.05M-0.36M-0.35M
Enterprise Value Growth (1y) (Quarter)
-791.18%-54,733.50%-1,123.18%21.04%14.39%9.15%4.56%9.99%19.86%26.90%32.05%31.92%33.83%20.85%22.60%25.46%28.66%36.09%33.21%32.06%
Enterprise Value Growth (3y) (Quarter)
-97.11%-92.35%-88.91%-614.57%-105.16%21.49%23.15%19.29%20.53%22.99%27.68%28.22%29.44%29.88%
Enterprise Value Growth (5y) (Quarter)
-37.84%-35.67%-33.49%-184.24%-40.27%24.52%
Enterprise Value (QoQ) (Quarter)
4.00%8.47%6.28%4.11%-4.08%2.86%1.56%9.57%7.33%11.38%8.50%9.39%9.94%-6.00%10.52%12.74%13.80%5.04%6.49%11.24%
FCF Margin Growth (1y) (Quarter)
-1.43M84.10M0.38M4.06M1.45M-83.97M-0.12M-0.44M
FCF Margin Growth (3y) (Quarter)
-0.06M-0.43M1.42M
FCF Margin (QoQ) (Quarter)
2.63M85.40M-83.97M-673.000.02M-0.03M-0.11M-0.33M
Interest Coverage Ratio Growth (1y) (Quarter)
-147.96%110.60%114.40%-4,615.19%-291.58%-274.42%-17,738.04%91.20%91.91%39.08%31.74%-35.36%-38.49%-730.93%54.36%67.06%43.48%
Interest Coverage Ratio Growth (3y) (Quarter)
43.56%22.85%14.60%-885.81%25.06%46.51%-94.66%-30.35%-121.25%-284.74%66.02%17.52%
Interest Coverage Ratio Growth (5y) (Quarter)
53.65%44.75%-25.82%-212.60%28.44%
Interest Coverage Ratio (QoQ) (Quarter)
2,744.99%-92.50%2,976.05%-168.83%-20.71%93.18%-310,956.44%99.97%-11.07%48.63%-348,422.64%99.93%-13.64%-208.23%-19,043.32%99.95%-94.99%
Net Margin Growth (1y) (Quarter)
-3.70M168.55M0.41M4.83M3.72M-168.22M-0.39M-0.72M
Net Margin Growth (3y) (Quarter)
-0.32M-0.63M3.70M
Net Margin (QoQ) (Quarter)
1.11M171.90M-168.19M0.01M0.00M-0.05M-0.36M-0.32M
Operating Margin Growth (1y) (Quarter)
-2.91M166.95M0.29M4.82M2.93M-166.72M-0.46M-0.80M
Operating Margin Growth (3y) (Quarter)
-0.39M-0.70M2.91M
Operating Margin (QoQ) (Quarter)
1.90M169.59M-166.68M0.01M0.00M-0.05M-0.42M-0.33M
Return on Assets Growth (1y) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Assets Growth (3y) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M-1.00-1.000.00M0.00M
Return on Assets Growth (5y) (Quarter)
0.00M0.00M
Return on Assets (QoQ) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Capital Employed Growth (1y) (Quarter)
720.000.00M0.00M0.00M411.00-0.00M-0.00M-0.00M-0.00M-0.00M316.00-276.00-0.00M-0.00M-0.00M-0.00M-0.00M448.00
Return on Capital Employed Growth (3y) (Quarter)
-0.00M-0.00M-0.00M-0.00M-0.00M-0.01M-0.01M-0.01M-0.01M-0.00M
Return on Capital Employed Growth (5y) (Quarter)
-0.00M-0.00M
Return on Capital Employed (QoQ) (Quarter)
149.00-240.00318.000.00M472.00-320.00-875.00-0.00M-0.00M53.00-84.0071.00276.00-539.00-869.00-0.00M-0.00M54.00795.00954.00
Return on Invested Capital (QoQ) (Quarter)
197.0077.00
Return on Sales Growth (1y) (Quarter)
-370.000.02M41.00483.00372.00-0.02M-39.00-72.00-12.00-88.00-173.0010.0087.00-5.000.00M
Return on Sales Growth (3y) (Quarter)
-32.00-63.00-10.00-55.00-171.00370.00-0.02M-6.00-1.00
Return on Sales Growth (5y) (Quarter)
-4.0032.00
Return on Sales (QoQ) (Quarter)
111.000.02M-0.02M1.000.00M-5.00-36.00-32.0061.00-81.00-120.00-4.001.00